Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 10, 2012, Pages 613-618

  Shata, Mohamed T ^a   Daef, Enas A ^b   Zaki, Maysaa E ^c   Abdelwahab, Sayed F ^d,e   Marzuuk, Naglaa M ^b   Sobhy, Maha ^e   Rafaat, Marwa ^b   Abdelbaki, Liala ^b   Nafeh, Mohamed A ^b   Hashem, Mohamed ^e,f   El Kamary, Samer S ^f   Shardell, Michelle D ^f   Mikhail, Nabiel N ^g   Strickland, George T ^f   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Assiut University Faculty of Medicine   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d Minia University   (Egypt)

^e VACSERA   (Egypt)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g ASSIUT UNIVERSITY   (Egypt)

Author keywords

Egypt; Hepatitis E; Humoral immune response; Morbidity; Viral hepatitis; Waterborne outbreak

Indexed keywords

EPITOPE; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; EGYPT; FAMILY; FEMALE; HEPATITIS E; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORBIDITY; PRESCHOOL CHILD; RURAL AREA; SCHOOL CHILD; SEROCONVERSION; VIRUS INFECTION; VIRUS TRANSMISSION;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EGYPT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNITY, HUMORAL; MALE; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS E VIRUS;

EID: 84865965161     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2012.07.004     Document Type: Article

References (29)

1. Krawczynski K., Kamili S., Aggarwal R. Global epidemiology and medical aspects of hepatitis E. Forum (Genova) 2001, 11:166-179.
2. Teshale E.H., Grytdal S.P., Howard C., et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010, 50:1006-1010.
3. Bendall R., Ellis V., Ijaz S., Thurairajah P., Dalton H.R. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008, 80:95-101.
4. Eldin S.S., Seddik I., Daef E.A., et al. Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt. Egypt J Immunol 2010, 17:73-86.
5. Khuroo M.S., Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003, 10:61-69.
6. Aggarwal R., Naik S.R. Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol 1994, 21:718-723.
7. Fix A.D., Abdel-Hamid M., Purcell R.H., et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000, 62:519-523.
8. Stoszek S.K., Abdel-Hamid M., Saleh D.A., et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006, 100:95-101.
9. Stoszek S.K., Engle R.E., Abdel-Hamid M., et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg 2006, 100:89-94.
10. Meky F.A., Stoszek S.K., Abdel-Hamid M., et al. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis 2006, 42:628-633.
11. Zakaria S., Fouad R., Shaker O., et al. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin Infect Dis 2007, 44:e30-e36.
12. Zhou Y.H., Purcell R.H., Emerson S.U. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 2004, 22:2578-2585.
13. Arankalle V.A., Chadha M.S., Tsarev S.A., et al. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Natl Acad Sci U S A 1994, 91:3428-3432.
14. Khuroo M.S., Kamili S., Dar M.Y., Moecklii R., Jameel S. Hepatitis E and long-term antibody status. Lancet 1993, 341:1355.
15. Blackard J.T., Rouster S.D., Nady S., et al. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. J Clin Virol 2009, 46:140-144.
16. Kantala T., Maunula L., von Bonsdorff C.H., Peltomaa J., Lappalainen M. Hepatitis E virus in patients with unexplained hepatitis in Finland. J Clin Virol 2009, 45:109-113.
17. Chargelegue D., Stanley C.M., O'Toole C.M., Colvin B.T., Steward M.W. The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients. J Infect Dis 1995, 172:897-898.
18. Olszewska W., Obeid O.E., Steward M.W. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology 2000, 272:98-105.
19. Tsarev S.A., Tsareva T.S., Emerson S.U., et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994, 91:10198-10202.
20. Arankalle V.A., Chadha M.S., Chobe L.P. Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatol 1999, 30:199-204.
21. Purcell R.H., Nguyen H., Shapiro M., et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003, 21:2607-2615.
22. Bryan J.P., Tsarev S.A., Iqbal M., et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994, 170:517-521.
23. Shrestha M.P., Scott R.M., Joshi D.M., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903.
24. Delgado M.F., Coviello S., Monsalvo A.C., et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009, 15:34-41.
25. Bottiger B., Jensen I.P. Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol 1997, 8:105-111.
26. Shata M.T., Barrett A., Shire N.J., et al. Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay. J Immunol Methods 2007, 328:152-161.
27. Lin C.X., Wu T., Wu X.L., et al. Priming with an HEV Th epitope can improve the humoral immunogenicity of its native protein [in Chinese]. Sheng Wu Gong Cheng Xue Bao 2007, 23:310-314.
28. Srivastava R., Aggarwal R., Jameel S., et al. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol 2007, 20:56-65.
29. Pal R., Aggarwal R., Naik S.R., Das V., Das S., Naik S. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 2005, 20:1094-1101.